Rocephin and Magnesium drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Rocephin and Magnesium. Common interactions include abdominal pain among females and toxic epidermal necrolysis among males.
The phase IV clinical study analyzes what interactions people who take Rocephin and Magnesium have. It is created by eHealthMe based on reports of 190 people who take Rocephin and Magnesium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
190 people who take Rocephin and Magnesium together, and have interactions are studied.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,204 Rocephin users for its effectiveness, alternative drugs and more.
What is Magnesium?
Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 88,643 Magnesium users for its effectiveness, alternative drugs and more.
Number of Rocephin and Magnesium reports submitted per year:
Rocephin and Magnesium drug interactions by gender *:
Rocephin and Magnesium drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Rocephin and Magnesium?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Common Rocephin and Magnesium interactions:
- Cardiomegaly (increased size of heart than normal): 15 reports
- Enlarged heart: 15 reports
- Hypoglycaemia (deficiency of glucose in the bloodstream): 6 reports
- Hypoglycemia (low blood sugar): 6 reports
- Insulin shock: 6 reports
- Low blood sugar: 6 reports
Browse all drug interactions of Rocephin and Magnesium:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Rocephin interactions:
Browse all interactions between Rocephin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Magnesium interactions:
Browse all interactions between Magnesium and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and magnesium (the active ingredients of Rocephin and Magnesium, respectively), and Rocephin and Magnesium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Rocephin and Magnesium.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Retevmo and Appetite - Decreased - a second ago
- Retevmo and Appetite Decreased - 2 seconds ago
- Xeloda and Hypercalcaemia - 2 seconds ago
- Letrozole and Facial Paresis - 5 seconds ago
- Lipitor and Brain Surgery - 11 seconds ago
- Slow-K and Tagrisso drug interaction - 11 seconds ago
- Depakene and Brain Death - 33 seconds ago
- Mania Aggravated and Apraxia - 41 seconds ago
- Adrenal Cortex and Pancytopenia Aggravated - 54 seconds ago
- Tazidime and Norethindrone drug interaction - a minute ago